( March 30, 2026, 1:13 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on March 30 denied a petition for a writ of certiorari from a biotechnology company that told the high court that the Federal Circuit U.S. Court of Appeals wrongly shifted the burden of proof to the patentee; the Supreme Court thus left in place the Federal Circuit’s affirmaance of a U.S. Patent Trial and Appeal Board (PTAB) decision that rendered claims of the company’s patents describing gene-editing technologies invalid as anticipated....